Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bentrem

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Oncotarget|December 2, 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancerMichelle A Schultz, Andrew M Diaz, Sharon Smite, et al.
Surgery|June 9, 2026
Quantitative KRAS mutational burden by next-generation sequencing predicts outcomes in localized pancreatic cancerKrishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 14, 2025
Trends and Outcomes for Patients Receiving Neoadjuvant Therapy for Stage I-III Gastric Gastrointestinal Stromal TumorsCade F Bennett, Lauren M Janczewski, Dominic Vitello, et al.
Journal of the American College of Surgeons|January 16, 2017
Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional StudyGregory C Wilson, Shishir K Maithel, David Bentrem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic CancerKrishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Annals of Surgery|October 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant ChemotherapyDominic J Vitello, Dhavan Shah, Amy Wells, et al.
Annals of Surgical Oncology|July 18, 2009
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistulaSharon M Weber, Clifford S Cho, Nipun Merchant, et al.
Journal of the American College of Surgeons|February 21, 2016
Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?Alexander A Parikh, Amelia Maiga, David Bentrem, et al.
Journal of the American College of Surgeons|December 27, 2016
Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas ConsortiumCecilia G Ethun, Alexandra G Lopez-Aguiar, Timothy M Pawlik, et al.
The American Surgeon|February 12, 2018
The Hand-Assisted Laparoscopic Approach to Resection of Pancreatic Mucinous Cystic Neoplasms: An Underused Technique?Lauren M Postlewait, Cecilia G Ethun, Mia R McInnis, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Oncotarget|December 2, 2017
Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancerMichelle A Schultz, Andrew M Diaz, Sharon Smite, et al.
Surgery|June 9, 2026
Quantitative KRAS mutational burden by next-generation sequencing predicts outcomes in localized pancreatic cancerKrishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 14, 2025
Trends and Outcomes for Patients Receiving Neoadjuvant Therapy for Stage I-III Gastric Gastrointestinal Stromal TumorsCade F Bennett, Lauren M Janczewski, Dominic Vitello, et al.
Journal of the American College of Surgeons|January 16, 2017
Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional StudyGregory C Wilson, Shishir K Maithel, David Bentrem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic CancerKrishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Annals of Surgery|October 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant ChemotherapyDominic J Vitello, Dhavan Shah, Amy Wells, et al.
Annals of Surgical Oncology|July 18, 2009
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistulaSharon M Weber, Clifford S Cho, Nipun Merchant, et al.
Journal of the American College of Surgeons|February 21, 2016
Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?Alexander A Parikh, Amelia Maiga, David Bentrem, et al.
Journal of the American College of Surgeons|December 27, 2016
Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas ConsortiumCecilia G Ethun, Alexandra G Lopez-Aguiar, Timothy M Pawlik, et al.
The American Surgeon|February 12, 2018
The Hand-Assisted Laparoscopic Approach to Resection of Pancreatic Mucinous Cystic Neoplasms: An Underused Technique?Lauren M Postlewait, Cecilia G Ethun, Mia R McInnis, et al.
Pageof 4